Quantum Medical Transport, Inc. carries a market capitalization of 23,978.00, placing it among publicly traded companies globally. Its enterprise value stands at 82,816.01, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23,978.00 |
| Enterprise Value | 82,816.01 |
Quantum Medical Transport, Inc. currently has 450.27M shares outstanding.
| Shares Outstanding | 450.27M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.13, and the price-to-book ratio stands at -0.03.
| PE Ratio | N/A |
| PS Ratio | 0.13 |
| PB Ratio | -0.03 |
| P/TBV Ratio | -0.02 |
| P/FCF Ratio | -0.09 |
| P/OCF Ratio | -0.09 |
| EV / Sales | 0.75 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Quantum Medical Transport, Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -8.59, indicating conservative leverage, while an interest coverage ratio of -2.87 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | -8.59 |
| Debt / EBITDA | -0.27 |
| Interest Coverage | -2.87 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -6,156.36 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 317.09 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Quantum Medical Transport, Inc. generated 110,877.00 in revenue and converted that into -342,263.00 in net income, yielding earnings per share of -0.76. EBITDA reached -253,933.00, while operating income came in at -253,933.00.
| Revenue | 110,877.00 |
| Gross Profit | 80,913.00 |
| Operating Income | -253,933.00 |
| Pretax Income | -342,263.00 |
| Net Income | -342,263.00 |
| EBITDA | -253,933.00 |
| EBIT | -253,933.00 |
| Earnings Per Share (EPS) | -0.76 |
Quantum Medical Transport, Inc. holds 348.00 in cash and equivalents against 68,763.00 in total debt, resulting in a net debt position of 68,415.00. Total book value stands at -419,692.00, with working capital of -800,072.00 providing operational flexibility.
| Cash & Cash Equivalents | 348.00 |
| Total Debt | 68,763.00 |
| Net Debt | 68,415.00 |
| Equity (Book Value) | -419,692.00 |
| Book Value Per Share | -0.93 |
| Working Capital | -800,072.00 |
Quantum Medical Transport, Inc. produced -151,668.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -151,668.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -151,668.00 |
| FCF Per Share | -0.34 |
Quantum Medical Transport, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -229.02 and net profit margin of -308.69 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -229.02 |
| Pretax Margin | -308.69 |
| Profit Margin | -308.69 |
| EBITDA Margin | -229.02 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1,038.98 |
| FCF Yield | -1,053.18 |
Quantum Medical Transport, Inc.'s most recent stock split took place on December 10, 2010 with a 1000:1 split ratio.
| Last Split Date | 12/10/2010 |
| Split Ratio | 1000:1 |
Quantum Medical Transport, Inc. posts an Altman Z-Score of -210.13, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -210.13 |